Replies to post #215680 on Biotech Values

[marthambles]

So AGN is claiming that the RVNC results " do not support" an extended duration claim. I assume that this is based on the 2014 FDA guidance that would require the extended duration to maintain the efficacy shown at week 4 which has yet to be demonstrated. Comments welcome.